XASX
SBW
Market cap3mUSD
Feb 06, Last price
0.02AUD
Name
Shekel Brainweigh Ltd
Chart & Performance
P/E
—
P/S
0.08
EPS
—
Div Yield, %
—
Shrs. gr., 5y
11.87%
Rev. gr., 5y
10.39%
Revenues
41m
+7.76%
Net income
-6m
L+29.40%
CFO
-4m
L-47.17%
Earnings
Aug 20, 2025
Profile
Shekel Brainweigh Ltd., together with its subsidiaries, operates as a digital weighing technology company worldwide. It engages in the development, planning, assembly, and marketing of electronic weighing systems. The company operates through two divisions, Scales and Retail Innovation. The company provides physician, chair, personal floor, neonatal, handrail, wheelchair, multi-functional handrail, portable physician and baby, and low-profile personal scales under the Healthweigh brand name. It offers retail scales, including scanners, iPC, and checkout systems; force measurement weighing and scale solutions for the agricultural, manufacturing, and military industries, as well as for airport baggage check-in; and electronic weighing solutions for integration into healthcare, retail, industrial, and agricultural OEM applications. Further, the company provides Innovendi, an unattended automated locked vending machine system; product aware shelf kit; product aware bay; and the Micro market Capsule that allows retailers to provide 24/7 frictionless shopping solution. Shekel Brainweigh Ltd. was founded in 1971 and is based in East Melbourne, Australia.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 40,966 7.76% | 38,018 23.51% | ||||||
Cost of revenue | 44,397 | 41,576 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | (3,431) | (3,559) | ||||||
NOPBT Margin | ||||||||
Operating Taxes | 114 | 402 | ||||||
Tax Rate | ||||||||
NOPAT | (3,545) | (3,961) | ||||||
Net income | (5,712) 29.40% | (4,414) -51.04% | ||||||
Dividends | (38) | |||||||
Dividend yield | 0.24% | |||||||
Proceeds from repurchase of equity | 349 | 1,582 | ||||||
BB yield | -2.20% | -10.75% | ||||||
| Debt | ||||||||
Debt current | 15,316 | 11,217 | ||||||
Long-term debt | 9,930 | 17,464 | ||||||
Deferred revenue | ||||||||
Other long-term liabilities | 26 | 8,129 | ||||||
Net debt | 23,522 | 25,891 | ||||||
| Cash flow | ||||||||
Cash from operating activities | (3,724) | (7,048) | ||||||
CAPEX | (356) | (531) | ||||||
Cash from investing activities | 803 | 2,330 | ||||||
Cash from financing activities | 1,784 | 4,789 | ||||||
FCF | 16,896 | (7,863) | ||||||
| Balance | ||||||||
Cash | 1,724 | 2,790 | ||||||
Long term investments | ||||||||
Excess cash | 889 | |||||||
Stockholders' equity | (7,316) | 419 | ||||||
Invested Capital | 22,781 | 28,991 | ||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | 198,474 | 181,659 | ||||||
Price | 0.08 -1.23% | 0.08 -61.43% | ||||||
Market cap | 15,878 7.91% | 14,714 -54.01% | ||||||
EV | 40,437 | 41,470 | ||||||
EBITDA | (3,431) | (1,156) | ||||||
EV/EBITDA | ||||||||
Interest | 1,188 | 1,577 | ||||||
Interest/NOPBT | ||||||||